News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Redmile Group, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/03/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 492 shares
@ $0 |
|
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/27/2023 |
SC 13D
| Redmile Group, LLC reports a 6.6% stake in NEOLEUKIN THERAPEUTICS, INC. |
| 07/17/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 shares
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 2,812,500 options to buy
@ $8, valued at
$22.5M
|
|
| 06/28/2023 |
SC 13D/A
| Redmile Group, LLC reports a 9.9% stake in IGM Biosciences, Inc. |
| 06/16/2023 |
4
| Redmile Group, LLC (Director) has filed a Form 4 on Absci Corp|
Txns:
| Granted 53,100 options to buy
@ $1.68, valued at
$89.2k
|
|
| 06/15/2023 |
SC 13D/A
| Redmile Group, LLC reports a 44.7% stake in Augmedix, Inc. |
| 06/08/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $5.52, valued at
$220.8k
|
|
| 05/31/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Shattuck Labs, Inc.|
Txns:
| Granted 40,258 options to buy
@ $2.72, valued at
$109.5k
|
|
| 05/15/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Granted 494,853 shares
@ $0.2526, valued at
$125k
|
|
| 05/04/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Disposed of 5,000,000 shares
@ $3, valued at
$15M
Disposed of 7,446,146 shares
@ $3, valued at
$22.3M
Acquired 7,446,146 shares
@ $3, valued at
$22.3M
|
|
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 492 shares
@ $0 |
|
| 03/13/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on MedAvail Holdings, Inc.|
Txns:
| Granted 38,916,562 options to buy
@ $0.001, valued at
$38.9k
Granted 38,916,562 options to buy
@ $0.001, valued at
$38.9k
|
|
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G
| Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc. |
| 02/08/2023 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in OLD AYALA, Inc. |
| 02/03/2023 |
SC 13G/A
| Redmile Group, LLC reports a 9.7% stake in Stoke therapeutics, Inc. |
| 01/04/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 230 shares
@ $0 |
|
| 11/18/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Replimune Group, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/18/2022 |
4/A
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 30,481 shares
@ $5.0338, valued at
$153.4k
|
|
| 10/17/2022 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 30,481 shares
@ $5.0338, valued at
$153.4k
|
|
|
|
|